Ischemic stroke
Conditions
Interventions
Sponsors
Affiliated Hospital of Changchun University of Traditional Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Meet the diagnostic criteria of western medicine for ischemic stroke (acute phase); 2.Comply with the diagnostic criteria of TCM in the acute phase of ischemic stroke, the meridian (experimental phlegm-heat fu-organs); 3.The onset time is less than 14 days; 4.4<=NIHSS<15 points; 5.Aged 40-80 years; 6.The patient or the entrusted immediate family members sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Diagnose patients with other brain diseases based on head CT or MRI, such as cerebral hemorrhage, brain tumor, brain trauma, TIA; 2.Patients in a coma; 3.Patients need or have undergone thrombolysis or endovascular treatment; 4.People with allergies, allergic to test drugs or related ingredients; 5.Patients whose blood pressure is still less than 90/60mmHg or >=220mmHg/120mmHg after treatment; 6.Complicated with severe liver and kidney damage, and whose ALT, AST, Cr, and BUN levels are 1.5 times higher than normal; 7.Accompanied by other complications and complications that affect drug evaluation, such as severe cardiac insufficiency, severe mental illness, depression and dementia after stroke, cerebral hemorrhage after cerebral infarction, etc.; 8.Past ischemic stroke mRS score >= 2 points; 9.Disabled patients (blindness, deafness, dumbness, intellectual disability, mental disability, etc.) stipulated by the law, and physical disability caused by other diseases affect the assessors of neurological impairment; 10.Patients with bleeding tendency or severe bleeding within 3 months; 11.Suspected or true history of alcohol or drug abuse, or other circumstances that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator; 12.Menstrual women, pregnant women and lactating women, those who have a positive pregnancy test or have recent birth plans; 13.Participating in other clinical trials or participating in other drug clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified Rankin scale ;National Institutes of Health Neurological Deficit Score;Barthel scale;Traditional Chinese medicine Syndrome Elements Integral Scale; | — |
Countries
China
Contacts
Public ContactZhao Dexi
Changchun University of Chinese Medicine
Outcome results
None listed